Armata Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Armata Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2013 to Q3 2024.
  • Armata Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 36.2M shares, a 0.26% increase year-over-year.
  • Armata Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 36.1M shares, a 5.2% increase from 2022.
  • Armata Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 34.3M shares, a 42.3% increase from 2021.
  • Armata Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 24.1M shares, a 46.8% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 36.2M +93.1K +0.26% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 36.2M +86.4K +0.24% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 36.1M +79.9K +0.22% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 36.1M +1.78M +5.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 36.1M +48.3K +0.13% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 36.1M +68.5K +0.19% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 36M +7.05M +24.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 34.3M +10.2M +42.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 36M +11.2M +45.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 36M +11.2M +45.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 29M +8.54M +41.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 24.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 24.8M +6.43M +34.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 24.8M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 20.5M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 18.4M +8.84M +92.6% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-12
Q4 2019 7.83M +3.17M +68.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 9.55M +4.9M +105% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 7.51M +2.85M +61.3% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-14
Q1 2019 32.4M +19.1M +144% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-06
Q4 2018 4.65M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 4.65M -4.22M -47.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 4.65M -698K -13% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 13.3M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q3 2017 8.87M +7.76M +698% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 5.35M +4.48M +512% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q4 2016 984K -4.43M -81.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 1.11M -4.7M -80.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 874K -4.79M -84.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 5.88M +1.64M +38.6% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-12
Q4 2015 5.41M Oct 1, 2015 Dec 31, 2015 10-K 2016-03-30
Q3 2015 5.81M +2.07M +55.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 5.67M +2M +54.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 4.25M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q3 2014 3.74M -95.4M -96.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 3.67M -87M -95.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q3 2013 99.2M Jul 1, 2013 Sep 30, 2013 10-Q/A 2015-04-15
Q2 2013 90.6M Apr 1, 2013 Jun 30, 2013 10-Q/A 2015-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.